These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12370250)

  • 1. CD103 expression is required for destruction of pancreatic islet allografts by CD8(+) T cells.
    Feng Y; Wang D; Yuan R; Parker CM; Farber DL; Hadley GA
    J Exp Med; 2002 Oct; 196(7):877-86. PubMed ID: 12370250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of CD103 expression by CD8+ T cells responding to renal allografts.
    Wang D; Yuan R; Feng Y; El-Asady R; Farber DL; Gress RE; Lucas PJ; Hadley GA
    J Immunol; 2004 Jan; 172(1):214-21. PubMed ID: 14688328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role for CD103+CD8+ effectors in promoting tubular injury following allogeneic renal transplantation.
    Yuan R; El-Asady R; Liu K; Wang D; Drachenberg CB; Hadley GA
    J Immunol; 2005 Sep; 175(5):2868-79. PubMed ID: 16116173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An anti-CD103 antibody-drug conjugate prolongs the survival of pancreatic islet allografts in mice.
    Xue D; Liu P; Chen W; Zhang C; Zhang L
    Cell Death Dis; 2019 Sep; 10(10):735. PubMed ID: 31570722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An essential contribution by IFN-gamma to CD8+ T cell-mediated rejection of pancreatic islet allografts.
    Diamond AS; Gill RG
    J Immunol; 2000 Jul; 165(1):247-55. PubMed ID: 10861058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-{beta}-dependent CD103 expression by CD8(+) T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease.
    El-Asady R; Yuan R; Liu K; Wang D; Gress RE; Lucas PJ; Drachenberg CB; Hadley GA
    J Exp Med; 2005 May; 201(10):1647-57. PubMed ID: 15897278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the contribution of CD4+ T cells to proislet and islet allograft rejection correlate with constitutive class II MHC alloantigen expression.
    Simeonovic CJ; Brown DJ; Townsend MJ; Wilson JD
    Cell Transplant; 1996; 5(5):525-41. PubMed ID: 8889212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD103+ CTL accumulate within the graft epithelium during clinical renal allograft rejection.
    Hadley GA; Charandee C; Weir MR; Wang D; Bartlett ST; Drachenberg CB
    Transplantation; 2001 Nov; 72(9):1548-55. PubMed ID: 11707744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of anti-CD103 immunotoxin for saving islet allograft in context of transplantation.
    Zhang L; Hadley GA
    Chin Med J (Engl); 2010 Dec; 123(24):3644-51. PubMed ID: 22166645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the epithelial cell-specific integrin, CD103, by human CD8+ cytolytic T lymphocytes.
    Hadley GA; Rostapshova EA; Gomolka DM; Taylor BM; Bartlett ST; Drachenberg CI; Weir MR
    Transplantation; 1999 Jun; 67(11):1418-25. PubMed ID: 10385079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL.
    Hadley GA; Bartlett ST; Via CS; Rostapshova EA; Moainie S
    J Immunol; 1997 Oct; 159(8):3748-56. PubMed ID: 9378961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of integrin CD103 in promoting destruction of renal allografts by CD8 T cells.
    Hadley G
    Am J Transplant; 2004 Jul; 4(7):1026-32. PubMed ID: 15196058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient elimination of CD103-expressing cells by anti-CD103 antibody drug conjugates in immunocompetent mice.
    Mang Y; Zhao Z; Zeng Z; Wu X; Li Z; Zhang L
    Int Immunopharmacol; 2015 Jan; 24(1):119-27. PubMed ID: 25467246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An anti-CD103 immunotoxin promotes long-term survival of pancreatic islet allografts.
    Zhang L; Moffatt-Bruce SD; Gaughan AA; Wang JJ; Rajab A; Hadley GA
    Am J Transplant; 2009 Sep; 9(9):2012-23. PubMed ID: 19645708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Impact of T-bet and IFNγ on Pancreatic Islet Allograft Rejection.
    Besançon A; Demir Z; Goncalves T; Valette F; Panafieu E; Chatenoud L; You S
    Transplantation; 2018 Sep; 102(9):1496-1504. PubMed ID: 29757902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet allograft rejection by contact-dependent CD8+ T cells: perforin and FasL play alternate but obligatory roles.
    Sleater M; Diamond AS; Gill RG
    Am J Transplant; 2007 Aug; 7(8):1927-33. PubMed ID: 17617855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL25/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes.
    Ericsson A; Svensson M; Arya A; Agace WW
    Eur J Immunol; 2004 Oct; 34(10):2720-9. PubMed ID: 15368288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet allograft, islet xenograft, and skin allograft survival in CD8+ T lymphocyte-deficient mice.
    Desai NM; Bassiri H; Kim J; Koller BH; Smithies O; Barker CF; Naji A; Markmann JF
    Transplantation; 1993 Apr; 55(4):718-22. PubMed ID: 8475541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubulitis and epithelial cell alterations in mouse kidney transplant rejection are independent of CD103, perforin or granzymes A/B.
    Einecke G; Fairhead T; Hidalgo LG; Sis B; Turner P; Zhu LF; Bleackley RC; Hadley GA; Famulski KS; Halloran PF
    Am J Transplant; 2006 Sep; 6(9):2109-20. PubMed ID: 16869802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD103 deficiency prevents graft-versus-host disease but spares graft-versus-tumor effects mediated by alloreactive CD8 T cells.
    Liu K; Anthony BA; Yearsly MM; Hamadani M; Gaughan A; Wang JJ; Devine SM; Hadley GA
    PLoS One; 2011; 6(7):e21968. PubMed ID: 21779359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.